Results 181 to 190 of about 3,216,591 (304)

Psychometric Properties of the Choosing Wisely Questions in a Large Psychiatric Sample. [PDF]

Int J Methods Psychiatr Res
Bengtsson J, Andersson A, Forss Lilja N, Hultgren Farsani I, Lissbrant E, Wettermark B, Blomqvist I.   +6 more
europepmc   +1 more source

Exhibition Video: Pink: The History of a Punk, Pretty, Powerful Color

Curated by Dr. Valerie Steele, director of The Museum at FIT, "Pink: The History of a Punk, Pretty, Powerful Color" (September 7, 2018 – January 5, 2019) explores the changing significance of the color pink over the past three centuries.In this video, Dr.

core  

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann   +10 more
wiley   +1 more source

Multidimensional Emotional Disorder Inventory: Reliability and Validity in a Turkish Community Sample. [PDF]

Behav Sci (Basel)
Demir-Budakçıgil M, Şafak-Öztürk C, Aksu G, Şakiroğlu M, Rosellini AJ.   +4 more
europepmc   +1 more source

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

Molecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur, Joel Rodrigues Vitória, Manuel Saiselet, Ligia Craciun, Denis Larsimont, Anne Lefort, Frédérick Libert, Carine Maenhaut, Sabine Costagliola, Maxime Tarabichi, Mirian Romitti, Vincent Detours   +11 more
wiley   +1 more source

FIT Oral History: John Pomerantz (Part 2)

DATE INTERVIEWED: circa 1980sSUMMARY: Mildred Finger interviews John Pomerantz of Leslie Fay, Inc.BIOGRAPHY: "John J. Pomerantz, president of JJP Advisory, LLC, is former chairman and chief executive officer of Leslie Fay Company, Inc., a manufacturer of

core  

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

Molecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park, Kyongman An, Gyeonghwa Kim, Soo‐Nyun Choi, Hong‐Ki Lee, Keun Hur, Kyu‐Shik Jeong   +6 more
wiley   +1 more source

Psychometric properties of the Brazilian 14-Item Health Literacy Scale for people living with mental disorders: a cross-sectional study. [PDF]

Rev Assoc Med Bras (1992)
Barbosa MR, Maracci LM, Mota MJBB, Gheno EER, Strassburger Junior M, Alievi MF, Valentim OMMS, Kolankiewicz ACB.   +7 more
europepmc   +1 more source

FIT Oral History: John Pomerantz (Part 1)

DATE INTERVIEWED: November 11, 1981 & March 3, 1982SUMMARY: Mildred Finger interviews John Pomerantz of Leslie Fay, Inc.Mildred Finger interviewed John Pomerantz again at a later date, possibly also in 1982.

core